By www.reliableresearchiq.com
Global And United States Poxviridae Infections Drug Market Report & Forecast 2024-2031 Story
109
$ 4350
Poxviridae Infections Drug Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Bavarian Nordic A/S BioFactura, Inc. CEL-SCI Corporation Chimerix, Inc. China Biologic Products, Inc. CJ HealthCare Corp. EpiVax, Inc. N & N Pharmaceuticals Inc. SIGA Technologies, Inc. Takeda Pharmaceutical Company Limited Tonix Pharmaceuticals Holding Corp. Verrica Pharmaceuticals Inc.